| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8440773 | European Journal of Cancer | 2016 | 10 Pages |
Abstract
Our proposed computational framework to implement phase i trials in cancer can readily capture observed heterogeneous clinical outcomes and predict patient survival. Importantly, phase i trials can be used to optimise future clinical trial design.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Eunjung Kim, Vito W. Rebecca, Keiran S.M. Smalley, Alexander R.A. Anderson,